Institute of Metabolic Diseases, Guang' Anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Gut Microbes. 2023 Jan-Dec;15(1):2236749. doi: 10.1080/19490976.2023.2236749.
A growing amount of evidence has supported that gut microbiota plays a vital role in the reproductive endocrine system throughout a woman's whole life, and gut microbial β-glucuronidase (gmGUS) is a key factor in regulating host estrogen metabolism. Moreover, estrogen levels also influence the composition as well as the diversity of gut microbiota. In normal condition, the gmGUS-estrogen crosstalk maintains body homeostasis of physiological estrogen level. Once this homeostasis is broken, the estrogen metabolism will be disturbed, resulting in estrogen-related diseases, such as gynecological cancers, menopausal syndrome, etc. together with gut microbial dysbiosis, which may accelerate these pathological processes. In this review, we highlight the regulatory role of gmGUS on the physical estrogen metabolism and estrogen-related diseases, summarize the present evidence of the interaction between gmGUS and estrogen metabolism, and unwrap the potential mechanisms behind them. Finally, gmGUS may become a potential biomarker for early diagnosis of estrogen-induced diseases. Regulating gmGUS activity or transplanting gmGUS-producing microbes shows promise for treating estrogen-related diseases.
越来越多的证据表明,肠道微生物群在女性的整个生命周期中对生殖内分泌系统起着至关重要的作用,而肠道微生物 β-葡糖苷酸酶(gmGUS)是调节宿主雌激素代谢的关键因素。此外,雌激素水平也会影响肠道微生物群的组成和多样性。在正常情况下,gmGUS-雌激素相互作用维持着生理性雌激素水平的体内内稳态。一旦这种内稳态被打破,雌激素代谢就会紊乱,导致与雌激素相关的疾病,如妇科癌症、更年期综合征等,同时伴随着肠道微生物群失调,这可能会加速这些病理过程。在这篇综述中,我们强调了 gmGUS 对生理性雌激素代谢和与雌激素相关疾病的调节作用,总结了目前关于 gmGUS 与雌激素代谢相互作用的证据,并揭示了它们背后的潜在机制。最后,gmGUS 可能成为雌激素诱导疾病早期诊断的潜在生物标志物。调节 gmGUS 活性或移植产生 gmGUS 的微生物显示出治疗与雌激素相关疾病的潜力。